ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC38634-10mg |
|
1112993-18-6 |
Silvestrol aglycone (enantiomer)
|
0 | C27H26O8 | |
GC38634-5mg |
|
1112993-18-6 |
Silvestrol aglycone (enantiomer)
|
0 | C27H26O8 | |
GC38634-1mg |
|
1112993-18-6 |
Silvestrol aglycone (enantiomer)
|
0 | C27H26O8 | |
GC38634-10mM (in 1mL DMSO) |
|
1112993-18-6 |
Silvestrol aglycone (enantiomer)
|
0 | C27H26O8 | |
GC38633-100mg |
|
1834516-06-1 |
Fmoc-Ala-Ala-Asn-PABC-PNP
|
0 | C39H38N6O11 | |
GC38632-500mg |
|
1610769-13-5 |
PDP-C1-Ph-Val-Cit
|
0 | C26H37N7O5S2 | |
GC38632-100mg |
|
1610769-13-5 |
PDP-C1-Ph-Val-Cit
|
0 | C26H37N7O5S2 | |
GC38631-1g |
|
886209-60-5 |
Cyclooctyne-O-PFP ester
|
0 | C16H13F5O3 | |
GC38631-100mg |
|
886209-60-5 |
Cyclooctyne-O-PFP ester
|
0 | C16H13F5O3 | |
GC38630-100mg |
|
1800047-00-0 |
Lanraplenib succinate
|
0 | C23H25N9O.3/2C4H6O4 | |
GC38630-50mg |
|
1800047-00-0 |
Lanraplenib succinate
|
0 | C23H25N9O.3/2C4H6O4 | |
GC38630-25mg |
|
1800047-00-0 |
Lanraplenib succinate
|
0 | C23H25N9O.3/2C4H6O4 | |
GC38630-10mg |
|
1800047-00-0 |
Lanraplenib succinate
|
0 | C23H25N9O.3/2C4H6O4 | |
GC38630-5mg |
|
1800047-00-0 |
Lanraplenib succinate
|
0 | C23H25N9O.3/2C4H6O4 | |
GC38630-1mg |
|
1800047-00-0 |
Lanraplenib succinate
|
0 | C23H25N9O.3/2C4H6O4 | |
GC38629-5mg |
|
— |
Calcineurin substrate (TFA)
|
0 | C94H151F3N28O31 | |
GC38629-1mg |
|
— |
Calcineurin substrate (TFA)
|
0 | C94H151F3N28O31 | |
GC38629-500μg |
|
— |
Calcineurin substrate (TFA)
|
0 | C94H151F3N28O31 | |
GC38628-10mg |
|
58749-23-8 |
Licochalcone B
|
0 | C16H14O5 | |
GC38628-5mg |
|
58749-23-8 |
Licochalcone B
|
0 | C16H14O5 | |